Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly A Johnson

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Frontiers in Public Health|June 11, 2024
Overdose deaths before and during the COVID-19 pandemic in a US countyC Hendricks Brown, Kimberly A Johnson, Holly A Hills, et al.
Drug and Alcohol Dependence|October 17, 2025
Implementation opportunities for optimizing retention on buprenorphine treatment for people with opioid use disorder in West VirginiaRoman Ivasiy, Lynn M Madden, Judith Feinberg, et al.
Prevention Science : the Official Journal of the Society for Prevention Research|April 13, 2023
Normalization of Prevention Principles and Practices to Reduce Substance Use Disorders Through an Integrated Dissemination and Implementation FrameworkZili Sloboda, Kimberly A Johnson, Diana H Fishbein, et al.
Journal of Substance Abuse Treatment|June 19, 2018
Developing an opioid use disorder treatment cascade: A review of quality measuresArthur Robin Williams, Edward V Nunes, Adam Bisaga, et al.
Implementation Science : IS|February 25, 2025
Rollout trial designs in implementation research are often necessary and sometimes preferredGregory E Simon, Bryan R Garner, Justin D Smith, et al.
Inorganic Chemistry|August 5, 2010
Iridium Ziegler-type hydrogenation catalysts made from [(1,5-COD)Ir(mu-O2C8H15)](2) and AlEt3: spectroscopic and kinetic evidence for the Ir(n) species present and for nanoparticles as the fastest catalystWilliam M Alley, Isil K Hamdemir, Qi Wang, et al.
Cells|November 14, 2019
Treatment with Human Amniotic Suspension Allograft Improves Tendon Healing in a Rat Model of Collagenase-Induced TendinopathyLaura de Girolamo, Luiz Felipe Morlin Ambra, Carlotta Perucca Orfei, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|April 13, 2011
Industrial Ziegler-type hydrogenation catalysts made from Co(neodecanoate)2 or Ni(2-ethylhexanoate)2 and AlEt3: evidence for nanoclusters and sub-nanocluster or larger Ziegler-nanocluster based catalysisWilliam M Alley, Isil K Hamdemir, Qi Wang, et al.
Journal of Cardiac Failure|October 10, 2021
Polypharmacy in Palliative Care for Advanced Heart Failure: The PAL-HF ExperienceBradi B Granger, James A Tulsky, Brystana G Kaufman, et al.
Substance Abuse|June 3, 2022
Opioid use disorder Cascade of care framework design: A roadmapArthur Robin Williams, Kimberly A Johnson, Cindy Parks Thomas, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Frontiers in Public Health|June 11, 2024
Overdose deaths before and during the COVID-19 pandemic in a US countyC Hendricks Brown, Kimberly A Johnson, Holly A Hills, et al.
Drug and Alcohol Dependence|October 17, 2025
Implementation opportunities for optimizing retention on buprenorphine treatment for people with opioid use disorder in West VirginiaRoman Ivasiy, Lynn M Madden, Judith Feinberg, et al.
Prevention Science : the Official Journal of the Society for Prevention Research|April 13, 2023
Normalization of Prevention Principles and Practices to Reduce Substance Use Disorders Through an Integrated Dissemination and Implementation FrameworkZili Sloboda, Kimberly A Johnson, Diana H Fishbein, et al.
Journal of Substance Abuse Treatment|June 19, 2018
Developing an opioid use disorder treatment cascade: A review of quality measuresArthur Robin Williams, Edward V Nunes, Adam Bisaga, et al.
Implementation Science : IS|February 25, 2025
Rollout trial designs in implementation research are often necessary and sometimes preferredGregory E Simon, Bryan R Garner, Justin D Smith, et al.
Inorganic Chemistry|August 5, 2010
Iridium Ziegler-type hydrogenation catalysts made from [(1,5-COD)Ir(mu-O2C8H15)](2) and AlEt3: spectroscopic and kinetic evidence for the Ir(n) species present and for nanoparticles as the fastest catalystWilliam M Alley, Isil K Hamdemir, Qi Wang, et al.
Cells|November 14, 2019
Treatment with Human Amniotic Suspension Allograft Improves Tendon Healing in a Rat Model of Collagenase-Induced TendinopathyLaura de Girolamo, Luiz Felipe Morlin Ambra, Carlotta Perucca Orfei, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|April 13, 2011
Industrial Ziegler-type hydrogenation catalysts made from Co(neodecanoate)2 or Ni(2-ethylhexanoate)2 and AlEt3: evidence for nanoclusters and sub-nanocluster or larger Ziegler-nanocluster based catalysisWilliam M Alley, Isil K Hamdemir, Qi Wang, et al.
Journal of Cardiac Failure|October 10, 2021
Polypharmacy in Palliative Care for Advanced Heart Failure: The PAL-HF ExperienceBradi B Granger, James A Tulsky, Brystana G Kaufman, et al.
Substance Abuse|June 3, 2022
Opioid use disorder Cascade of care framework design: A roadmapArthur Robin Williams, Kimberly A Johnson, Cindy Parks Thomas, et al.
Pageof 2